Mårdh G, Anggård E
J Neurochem. 1984 Jan;42(1):43-6. doi: 10.1111/j.1471-4159.1984.tb09695.x.
A double isotope labelling technique was used to simultaneously determine the in vivo turnover rates of 4-hydroxy-3-methoxyphenylglycol (HMPG) and 4-hydroxy-3-methoxymandelic acid (HMMA, VMA) and the rate of HMPG oxidation to HMMA. Six healthy men were given intravenous injections of [2H3]HMPG and [2H6]HMMA and their plasma and urine samples analysed by gas chromatography--mass spectrometry (GC/MS) for the protium and deuterium species. HMPG and HMMA production rates were calculated by isotope dilution. The rate of HMPG oxidation to HMMA was obtained from the fraction of [2H3]HMPG recovered as [2H3]HMMA. The results showed that the entire production of HMMA, 1.11 +/- 0.21 mumol/h (mean +/- SE), could be accounted for by oxidation of HMPG, 1.49 +/- 0.31 mumol/h. In another experiment designed to avoid expansion of the HMPG body pool, a tracer dose of [14C]HMPG was given to the same subjects. The levels of [14C]HMPG and [14C]HMMA were measured in urine after extraction and separation by thin layer chromatography. Urinary excretion of endogenous HMPG and HMMA was determined by GC/MS. The results showed that the endogenous HMMA fraction of the total HMPG and HMMA urinary excretion rate, 0.57 +/- 0.04, was the same as the fraction of [14C]HMPG oxidized to [14C]HMMA, 0.62 +/- 0.01. Thus, HMPG is the main intermediate in the metabolic conversion of norepinephrine and epinephrine to HMMA in man.
采用双同位素标记技术同时测定4-羟基-3-甲氧基苯乙二醇(HMPG)和4-羟基-3-甲氧基扁桃酸(HMMA,VMA)的体内周转率以及HMPG氧化为HMMA的速率。给6名健康男性静脉注射[2H3]HMPG和[2H6]HMMA,并通过气相色谱-质谱联用(GC/MS)分析其血浆和尿液样本中的氢和氘同位素。通过同位素稀释法计算HMPG和HMMA的生成速率。HMPG氧化为HMMA的速率由回收的[2H3]HMMA占[2H3]HMPG的比例得出。结果显示,HMMA的总生成量为1.11±0.21μmol/h(平均值±标准误),可由HMPG的氧化量1.49±0.31μmol/h解释。在另一项旨在避免HMPG体内池扩大的实验中,给同一受试者注射示踪剂量的[14C]HMPG。通过薄层色谱提取和分离后,测量尿液中[14C]HMPG和[14C]HMMA的水平。通过GC/MS测定内源性HMPG和HMMA的尿排泄量。结果显示,内源性HMMA占HMPG和HMMA总尿排泄率的比例为0.57±0.04,与[14C]HMPG氧化为[14C]HMMA的比例0.62±0.01相同。因此,在人体中,HMPG是去甲肾上腺素和肾上腺素代谢转化为HMMA的主要中间体。